Viewing Study NCT00423150

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 5:05 PM

Ignite Modification Date: 2026-01-04 @ 4:55 AM

Study NCT ID: NCT00423150

Status: TERMINATED

Last Update Posted: 2017-06-08

First Post: 2006-11-30

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)

Sponsor: Merck Sharp & Dohme LLC

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module